Alto Neuroscience ANRO
NYSE ANRO
$23.23 -0.09 (-0.41%)
As of: Oct 22, 2026 · 11:41 AM EDT

Alto Neuroscience (ANRO) Other non-cash items (2023 - 2026)

Updated

Analysis

Alto Neuroscience (ANRO) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn
10 Alto Neuroscience 993.69 Mn 171.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 406,000.00
Dec 31, 2025 372,000.00
Mar 31, 2025 1.05 Mn
Dec 31, 2024 309,000.00
Mar 31, 2024 413,000.00
Dec 31, 2023 11,000.00
Sep 30, 2023 -226,000.00
Jun 30, 2023 -122,000.00
Mar 31, 2023 166,000.00
API Access

Alto Neuroscience Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ANRO&period=max&api_key=YOUR_API_KEY